Nxstage medical, inc. (NXTM)
CashFlow / Yearly
Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities:
Net loss

-15,325

-7,317

-16,260

-24,313

-18,561

-15,153

-21,402

-31,712

-43,467

Adjustments to reconcile net loss to net cash flow from operating activities:
Depreciation and amortization

33,754

32,637

30,715

27,697

24,848

23,673

23,087

22,379

20,778

Stock-based compensation

11,537

10,117

12,598

12,881

8,638

11,403

13,093

15,351

9,226

Other

-2,131

-2,445

-1,302

-1,877

-2,628

-3,517

-3,064

-2,319

-2,690

Changes in operating assets and liabilities:
Accounts receivable

-1,056

7,388

1,130

4,188

1,095

3,141

1,773

-235

2,208

Inventory

22,917

31,069

12,113

35,063

20,076

14,545

16,371

28,744

9,209

Prepaid expenses and other assets

1,045

68

77

2,214

484

1,623

1,491

877

-1,513

Accounts payable

-22

3,532

-2,775

-212

-2,233

839

-1,047

-2,781

2,568

Accrued expenses and other liabilities

-1,774

4,141

635

4,235

1,081

5,263

-324

10,065

-119

Deferred revenues

-2,593

-2,443

-2,353

-973

-4,887

-3,992

1,648

16,876

5,071

Net cash provided by operating activities

4,802

4,587

10,542

-20,273

-10,141

6,241

-1,516

3,111

-13,157

Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired

100

513

0

0

2,234

-

-

-

-

Purchase of cost method investment

2,500

0

0

-

-

-

-

-

-

Proceeds from sales of marketable securities

0

0

676

0

0

-

-

-

-

Purchases of property and equipment

9,194

8,848

11,537

20,097

16,246

7,694

5,156

1,556

1,725

Decrease in other assets

-

-

-

-

-

-

-

-340

340

Net cash used in investing activities

-11,794

-9,361

-10,861

-20,097

-18,480

-7,694

-5,156

-1,216

-2,065

Cash flows from financing activities:
Issuance of common stock

-

-

-

-

-

-

-

73,354

-

Issuance of shares under stock incentive plans, net of payroll taxes paid

12,003

5,994

6,663

11,133

5,484

5,248

7,965

12,446

673

Investment by noncontrolling interest holder

0

1,255

929

930

525

-

-

-

-

Purchase of treasury stock

-

-

-

-

-

522

2,533

4,583

-

Proceeds from loans, lines of credit and capital leases

452

0

1,275

0

1,136

-

-

-

39,895

Repayments on loans and lines of credit

164

384

143

98

38

-

46

54

30,537

Repayments on capital leases

1,306

1,590

1,391

1,448

1,352

-

-

-

-

Debt issuance costs

-

-

-

1,056

0

-

-

-

-

Net cash provided by financing activities

10,985

5,275

7,333

9,461

5,755

4,726

5,386

81,163

10,031

Foreign exchange effect on cash and cash equivalents

1,303

66

-833

-341

561

257

-144

-439

269

Increase in cash and cash equivalents

5,296

567

6,181

-31,250

-22,305

3,530

-1,430

82,619

-4,922

Cash paid for interest

-

-

-

-

-

-

-

-

4,749

Cash paid for taxes

-

-

-

-

-

-

-

-

401

Transfers from inventory to field equipment

-

-

-

-

-

-

-

-

10,315

Transfers from field equipment to deferred cost of revenues

-

-

-

-

-

-

-

-

7,358